Note: This document has been translated from the Japanese original for reference purposes only. In the event ofany discrepancy between this translated document and the Japanese original, the original shall prevail.

May 10, 2024
CompanyHeadquarters
Representative
Contact
Telephone
WebsiteTakara Bio Inc.
(Securities code: 4974; Prime Market)
Nojihigashi 7-4-38, Kusatsu, Shiga, Japan
Koichi Nakao, President & CEO
Takuya Kakemi, Executive Officer, in chargeof PR & IR Department(+81)77-565-6970
https://www.takara-bio.co.jp/

Notice Concerning Dividends from Surplus

Takara Bio Inc. hereby announces that the resolution to distribute dividends from surplus with a record date ofMarch 31, 2024, at the meeting of the Board of Directors held on May 10, 2024, as follows. This matter will be
discussed at the Ordinary General Meeting of Shareholders to be held on June 21, 2024.
1. Details of dividends
Determined amount

Most recent dividend
forecast (Announced onMay 11, 2023)

Results for previous
fiscal year (Year ended
March 31, 2023)

March 31, 2024

March 31, 2024

March 31, 2023

¥17.00¥17.00¥42.00Total dividend amount¥2,047 million-¥5,057 million

Effective dateJune 24, 2024-

June 26, 2023

Dividend source

Retained earnings-

Retained earnings

Record date
Dividend per share

2. Reason
Our basic policy is to return profits to shareholders based on a comprehensive consideration of our operating
results and financial position, and we consider the return of profits to shareholders to be an important management
issue, while ensuring that we retain sufficient internal reserves in order to actively carry out research anddevelopment activities. Specifically, we plan to pay dividends of retained earnings to 35% of the expected net
income in the consolidated financial statements without taking into consideration the extraordinary gains or losses.
From the perspective of improving capital efficiency, we decided to pay a year-end dividend of ¥17.00 per share(approximately 87% of the expected net income) for the year ended March 31, 2024, as announced on May 11,2023.

(Reference) Breakdown of annual dividends
Annual dividends
Record Date Second quarter-end
Actual results for the current fiscal year
Actual results for the previous fiscal year
(Fiscal year ended March 31, 2023)

Fiscal-year end

Total

¥0.00

¥17.00¥17.00¥0.00¥42.00¥42.00Forward-Looking Statements
Statements contained in these materials with respect to the Company’s current plans, forecasts, strategies and beliefs that are
not historical facts are forward-looking statements about the further performance of the Company and its consolidated
subsidiaries. These statements are based on management’s assumptions and beliefs in light of information currently available
to it, but are based on a number of assumptions and beliefs derived from information that contains significant risks anduncertainties. Actual results may differ materially from these forecasts due to various factors. Factors that could influence
actual results include, but are not limited to, economic conditions, especially trends in consumer spending, as well as
exchange rate fluctuations, changes in laws and government systems, pressure from competitors’ prices and productstrategies, declines in selling power of the Company’s existing and new products, disruptions to production, violations of ourintellectual property rights, rapid advances in technology, and unfavorable verdicts in major litigation.